2022 Q4 Form 10-K Financial Statement
#000165495422014390 Filed on October 31, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2022 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Gross Profit | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Gross Profit Margin | |||
Selling, General & Admin | $51.65K | $32.16K | $152.5K |
YoY Change | 0.29% | -18.83% | -13.8% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $51.65K | $32.16K | $152.5K |
YoY Change | 0.3% | -18.83% | -13.8% |
Operating Profit | -$51.65K | -$32.16K | -$152.5K |
YoY Change | 0.3% | -18.83% | -14.28% |
Interest Expense | $1.585K | -$1.270K | $15.24K |
YoY Change | -20.11% | -98.43% | -116.38% |
% of Operating Profit | |||
Other Income/Expense, Net | -$104.00 | $0.00 | $3.219K |
YoY Change | -87.12% | ||
Pretax Income | -$51.76K | -$34.44K | -$149.3K |
YoY Change | -3.22% | -75.64% | -38.56% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$51.76K | -$34.44K | -$149.3K |
YoY Change | 81.55% | -75.64% | -38.56% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | -$627.30 | -$428.20 | -$1.916K |
COMMON SHARES | |||
Basic Shares Outstanding | 87.51M shares | 77.91M | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.790K | $25.81K | $25.81K |
YoY Change | -85.17% | 2560.82% | 2560.82% |
Cash & Equivalents | $2.791K | $25.81K | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $2.791K | $25.81K | $25.81K |
YoY Change | -85.17% | 2569.39% | 2560.82% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $2.791K | $25.81K | $25.81K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $2.791K | $25.81K | $25.81K |
YoY Change | -85.17% | 2569.39% | 2560.82% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $69.51K | $48.36K | $76.76K |
YoY Change | 9.85% | -15.06% | -16.24% |
Accrued Expenses | $307.0K | $305.4K | $305.4K |
YoY Change | -10.22% | -12.32% | -12.32% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $79.00K | $79.00K | $79.00K |
YoY Change | -32.6% | -40.25% | -40.25% |
Long-Term Debt Due | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Total Short-Term Liabilities | $489.9K | $461.2K | $461.2K |
YoY Change | -11.27% | -22.78% | -22.77% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $489.9K | $461.2K | $461.2K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $489.9K | $461.2K | $461.2K |
YoY Change | -11.27% | -22.78% | -22.77% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$3.443M | -$3.391M | |
YoY Change | 3.58% | 4.6% | |
Common Stock | $82.51K | $82.51K | |
YoY Change | 8.49% | 13.31% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$487.1K | -$435.4K | -$435.4K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $2.791K | $25.81K | $25.81K |
YoY Change | -85.17% | 2569.39% | 2560.82% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$51.76K | -$34.44K | -$149.3K |
YoY Change | 81.55% | -75.64% | -38.56% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$23.02K | -$33.16K | -$165.7K |
YoY Change | -54.1% | 17.71% | -1.87% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cash From Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $200.6K | ||
YoY Change | 23.04% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $0.00 | 35.00K | $190.6K |
YoY Change | -100.0% | 94.44% | 16.9% |
NET CHANGE | |||
Cash From Operating Activities | -$23.02K | -33.16K | -$165.7K |
Cash From Investing Activities | $0.00 | 0.000 | $0.00 |
Cash From Financing Activities | $0.00 | 35.00K | $190.6K |
Net Change In Cash | -$23.02K | 1.840K | $24.85K |
YoY Change | -229.0% | -118.09% | -523.27% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$23.02K | -$33.16K | -$165.7K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
967 | usd |
CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001415744 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--07-31 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Entity Address Country
EntityAddressCountry
|
CA | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-07-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
333-146934 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
NORTHERN MINERALS & EXPLORATION LTD. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
98-0557171 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
881 West State Road | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Pleasant Grove | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
UT | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
84062 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
801 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
885-9260 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q1 | dei |
Entity Public Float
EntityPublicFloat
|
6617082 | usd |
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
87509357 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
457 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Haynie & Company | |
CY2021Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
109000 | usd |
CY2022Q3 | nmex |
Loans Payable Related Party
LoansPayableRelatedParty
|
0 | usd |
CY2021Q3 | nmex |
Loans Payable Related Party
LoansPayableRelatedParty
|
23210 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
461177 | usd |
CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
597190 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
461177 | usd |
CY2021Q3 | us-gaap |
Cash
Cash
|
967 | usd |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Salt Lake City, Utah | |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
597190 | usd |
CY2022Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2021Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2021Q3 | us-gaap |
Assets
Assets
|
967 | usd |
CY2021Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
56936 | usd |
CY2021Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
34700 | usd |
CY2021Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
348344 | usd |
CY2022Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
0 | usd |
CY2021Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
25000 | usd |
CY2022Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
79000 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2021Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
87509357 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
82509357 | shares |
CY2021Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
72818338 | shares |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
82509 | usd |
CY2021Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
72819 | usd |
CY2022Q3 | nmex |
Common Stock To Be Issued
CommonStockToBeIssued
|
0 | usd |
CY2021Q3 | nmex |
Common Stock To Be Issued
CommonStockToBeIssued
|
18000 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
2873468 | usd |
CY2021Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
2555016 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3391341 | usd |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3242058 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-435364 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-596223 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
25813 | usd |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
967 | usd |
CY2022 | us-gaap |
Officers Compensation
OfficersCompensation
|
26400 | usd |
CY2021 | us-gaap |
Officers Compensation
OfficersCompensation
|
26400 | usd |
CY2022 | nmex |
Consulting Related Party
ConsultingRelatedParty
|
65000 | usd |
CY2021 | nmex |
Consulting Related Party
ConsultingRelatedParty
|
60000 | usd |
CY2022 | nmex |
Consulting
Consulting
|
0 | usd |
CY2021 | nmex |
Consulting
Consulting
|
8000 | usd |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
35615 | usd |
CY2021 | us-gaap |
Professional Fees
ProfessionalFees
|
49566 | usd |
CY2022 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
0 | usd |
CY2021 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
1000 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
25487 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
32944 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
152502 | usd |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
177910 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-152502 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-177910 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
15235 | usd |
CY2021 | nmex |
Common Stock Issued For Cash Related Party Amount
CommonStockIssuedForCashRelatedPartyAmount
|
83000 | usd |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
93017 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
2287 | usd |
CY2021 | us-gaap |
Other Income
OtherIncome
|
25000 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
17167 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
38616 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2021 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
28800 | usd |
CY2022 | nmex |
Loss On Conversion Of Debt
LossOnConversionOfDebt
|
1000 | usd |
CY2021 | nmex |
Loss On Conversion Of Debt
LossOnConversionOfDebt
|
6857 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
3219 | usd |
CY2022 | us-gaap |
Income Loss From Subsidiaries Before Tax
IncomeLossFromSubsidiariesBeforeTax
|
-149283 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-149283 | usd |
CY2022 | nmex |
Net Loss Per Share From Operations Basic And Diluted
NetLossPerShareFromOperationsBasicAndDiluted
|
-0.00 | |
CY2021 | nmex |
Net Loss Per Share From Operations Basic And Diluted
NetLossPerShareFromOperationsBasicAndDiluted
|
-0.00 | |
CY2022 | nmex |
Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
|
77905754 | shares |
CY2021 | nmex |
Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
|
68102636 | shares |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-751793 | usd |
CY2021 | nmex |
Common Stock Issued For Cash Amount
CommonStockIssuedForCashAmount
|
80000 | usd |
CY2021 | nmex |
Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
|
235538 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-242968 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-596223 | usd |
CY2022 | nmex |
Common Stock Issued For Cash Amount
CommonStockIssuedForCashAmount
|
52550 | usd |
CY2022 | nmex |
Common Stock Issued For Cash Related Party Amount
CommonStockIssuedForCashRelatedPartyAmount
|
148000 | usd |
CY2022 | nmex |
Common Stock Issued For Conversion Of Debt And Accrued Interest Amount
CommonStockIssuedForConversionOfDebtAndAccruedInterestAmount
|
54400 | usd |
CY2022 | nmex |
Common Stock Issued For Conversion Of Debt And Accrued Interest Related Party Amount
CommonStockIssuedForConversionOfDebtAndAccruedInterestRelatedPartyAmount
|
55092 | usd |
CY2022 | us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
100 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-149283 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-435364 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-149283 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-242968 | usd |
CY2022 | nmex |
Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
|
-17167 | usd |
CY2021 | nmex |
Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
|
38616 | usd |
CY2022 | nmex |
Loss On Conversion Of Debts
LossOnConversionOfDebts
|
1000 | usd |
CY2021 | nmex |
Loss On Conversion Of Debts
LossOnConversionOfDebts
|
6857 | usd |
CY2022 | nmex |
Loss On Disposal Of Oil Rights
LossOnDisposalOfOilRights
|
0 | usd |
CY2021 | nmex |
Loss On Disposal Of Oil Rights
LossOnDisposalOfOilRights
|
-28800 | usd |
CY2022 | nmex |
Cost Of Borrowing
CostOfBorrowing
|
0 | usd |
CY2021 | nmex |
Cost Of Borrowing
CostOfBorrowing
|
72631 | usd |
CY2022 | nmex |
Increase Decrease In Accounts Receivables
IncreaseDecreaseInAccountsReceivables
|
0 | usd |
CY2021 | nmex |
Increase Decrease In Accounts Receivables
IncreaseDecreaseInAccountsReceivables
|
-1146 | usd |
CY2022 | nmex |
Increase Decrease In Other Receivable
IncreaseDecreaseInOtherReceivable
|
0 | usd |
CY2021 | nmex |
Increase Decrease In Other Receivable
IncreaseDecreaseInOtherReceivable
|
-10000 | usd |
CY2022 | nmex |
Increase Decrease In Accounts Payable And Accrued Liability
IncreaseDecreaseInAccountsPayableAndAccruedLiability
|
-9189 | usd |
CY2021 | nmex |
Increase Decrease In Accounts Payable And Accrued Liability
IncreaseDecreaseInAccountsPayableAndAccruedLiability
|
-39345 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
-6300 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
15235 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-165704 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-168873 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2022 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
15000 | usd |
CY2021 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
5000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
200550 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
163000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
190550 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
163000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
24846 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-5873 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
967 | usd |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6840 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
25813 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
967 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
CY2022 | nmex |
Conversion Of Debt And Accrued Interest
ConversionOfDebtAndAccruedInterest
|
108491 | usd |
CY2021 | nmex |
Conversion Of Debt And Accrued Interest
ConversionOfDebtAndAccruedInterest
|
166580 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p> | |
CY2022 | nmex |
Sold Price Per Share
SoldPricePerShare
|
0.10 | |
CY2022 | nmex |
Sold Shares Of Common Stock Cash Proceeds
SoldSharesOfCommonStockCashProceeds
|
5000 | usd |
CY2022 | nmex |
Loan Payble Converted Into Shares Of Common Stock
LoanPaybleConvertedIntoSharesOfCommonStock
|
310000 | shares |
CY2022 | nmex |
Interest
Interest
|
0.24 | pure |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1911330 | shares |
CY2022Q3 | nmex |
Retained Earnings Accumulated Deficit1
RetainedEarningsAccumulatedDeficit1
|
3391341 | usd |
CY2019Q1 | nmex |
Acquisition Percentage
AcquisitionPercentage
|
0.80 | pure |
CY2022Q3 | nmex |
Accrued Liabilities Winnemucca
AccruedLiabilitiesWinnemucca
|
285453 | usd |
CY2021Q3 | nmex |
Accrued Liabilities Winnemucca
AccruedLiabilitiesWinnemucca
|
285453 | usd |
CY2021 | nmex |
Reduction In The Liabilities
ReductionInTheLiabilities
|
285453 | usd |
CY2022 | nmex |
Gains Losses On Extinguishment Of Debt1
GainsLossesOnExtinguishmentOfDebt1
|
23616 | usd |
CY2022Q3 | nmex |
Convertible Notes
ConvertibleNotes
|
50000 | usd |
CY2022Q3 | nmex |
Loan And Interest Per Unit
LoanAndInterestPerUnit
|
0.08 | |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.30 | |
CY2014Q3 | nmex |
Received Amount Unrelated Party
ReceivedAmountUnrelatedParty
|
35000 | usd |
CY2018Q3 | nmex |
Convertible Per Share
ConvertiblePerShare
|
0.04 | |
CY2018Q3 | nmex |
Warrant Exercisable Price
WarrantExercisablePrice
|
0.08 | |
CY2018Q3 | nmex |
Bear Interest
BearInterest
|
0.08 | pure |
CY2022 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
3822659 | shares |
CY2022 | nmex |
Conversion Of Stock Shares In To Warrants
ConversionOfStockSharesInToWarrants
|
1911330 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.04 | |
CY2022 | nmex |
Loss On Conversion
LossOnConversion
|
6857 | usd |
CY2022Q3 | nmex |
Repayment Of Loan
RepaymentOfLoan
|
15000 | usd |
CY2021Q3 | nmex |
Convertible Promissory Note Principal Amount
ConvertiblePromissoryNotePrincipalAmount
|
15000 | usd |
CY2021Q3 | nmex |
Convertible Promissory Note Accrued Interest
ConvertiblePromissoryNoteAccruedInterest
|
2400 | usd |
CY2022Q3 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
13585 | usd |
CY2021 | nmex |
Sold Shares Of Common Stock
SoldSharesOfCommonStock
|
2667200 | shares |
CY2021 | nmex |
Sold Price Per Share
SoldPricePerShare
|
0.03 | |
CY2021 | nmex |
Sold Shares Of Common Stock Cash Proceeds
SoldSharesOfCommonStockCashProceeds
|
80000 | usd |
CY2021Q2 | nmex |
Issued Shares Of Common Stock To Foster S Zeiders
IssuedSharesOfCommonStockToFosterSZeiders
|
5000000 | shares |
CY2021 | nmex |
Converted Note Into Shares Of Common Stock
ConvertedNoteIntoSharesOfCommonStock
|
3822659 | shares |
CY2022 | nmex |
Sold Shares Of Common Stock
SoldSharesOfCommonStock
|
50000 | shares |
CY2022 | nmex |
Converted Note Into Shares Of Common Stock
ConvertedNoteIntoSharesOfCommonStock
|
435000 | shares |
CY2022 | nmex |
Warrant Issued
WarrantIssued
|
1911330 | usd |
CY2022 | nmex |
Fair Value Of Warrant
FairValueOfWarrant
|
72631 | shares |
CY2022 | nmex |
Stock Price
StockPrice
|
4.00 | usd |
CY2022 | nmex |
Exercise Price
ExercisePrice
|
8.00 | usd |
CY2022 | nmex |
Warrant Period
WarrantPeriod
|
2-year | |
CY2022 | nmex |
Volatility Rate
VolatilityRate
|
3.13 | pure |
CY2022 | nmex |
Risk Free Interest Rate
RiskFreeInterestRate
|
0.0019 | pure |
CY2022 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
5000000 | shares |
CY2022 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
600000 | shares |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
31300 | usd |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
231000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
3400 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
194600 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-34700 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-425600 | usd |
CY2022 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
0 | usd |
CY2021 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
0 | usd |
CY2022Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
108200 | usd |
CY2021Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
250700 | usd |
CY2022Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
108200 | usd |
CY2021Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
250700 | usd |
CY2022Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2021Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022Q3 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
416000 | usd |
CY2022 | nmex |
Corporate Tax Rate
CorporateTaxRate
|
0.21 | pure |